The Silverlined Heart

FOR THE BENEFIT OF THE PUBLIC TO IMPROVE THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH THE RESEARCH AND DEVELOPMENT OF NEW TECHNOLOGIES IN PARTICULAR BUT NOT EXCLUSIVELY BY:-1. ESTABLISHING AND DEVELOPING THE SAFE USE OF NEW TECHNOLOGIES IN INTERVENTIONAL CARDIOLOGY2. SUPPORTING THE DESIGN AND USE OF EARLY DEVICES3. INVESTIGATING AND DEVELOPING NEW CONCEPTS IN PRE-CLINICAL STUDIES4. MAINTAINING AND ANALYSING PATIENT DATABASES TO MONITOR PROGRESS OF NEW TECHNOLOGYFOR THE BENEFIT OF THE PUBLIC TO IMPROVE THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH THE DEVELOPMENT OF NEW MEDICAL TREATMENTS IN PARTICULAR BUT NOT EXHAUSTED BY:-1. ESTABLISHING AND ADVANCING THE SAFE USE OF NEW THERAPIES IN INTERVENTIONAL CARDIOLOGY2. EXPANDING THE SCOPE OF TREATMENTS AVAILABLE FOR PATIENTS WITH CARDIOVASCULAR DISEASE BY DEVELOPING INNOVATIVE CLINICAL TRIALS3. EVALUATING PROMISING CONCEPTS BY DESIGNING, IMPLEMENTING AND MONITORING ALL PHASES OF HUMAN CLINICAL TRIALS.FOR THE BENEFIT OF THE PUBLIC TO IMPROVE THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH THE INCREASED DISSEMINATION OF INFORMATION REGARDING APPROPRIATE TREATMENTS FOR PEOPLE WITH CARDIOVASCULAR DISEASE IN PARTICULAR BUT NOT EXHAUSTED BY:-1. EDUCATING HEALTH CARE PROFESSIONALS AND THE PUBLIC AT LARGE ABOUT APPROPRIATE AND EFFECTIVE TREATMENTS FOR CARDIOVASCULAR DISEASE2. ESTABLISHING PARTNERSHIP AND CO-OPERATION WITH PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES AND OTHER CARDIOVASCULAR CLINICAL RESEARCH CENTRES3. ESTABLISHING PARTNERSHIPS AND CO-OPERATION WITH THE NHS4. CONTRIBUTING TO CARDIOVASCULAR LITERATURE FOR BOTH HEALTH CARE PROFESSIONALS AND THE PUBLIC5. ORGANISING CONFERENCES AND EDUCATIONAL MEETINGS